Illumina Net Worth

Illumina Net Worth Breakdown

  ILMN
The net worth of Illumina is the difference between its total assets and liabilities. Illumina's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Illumina's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Illumina's net worth can be used as a measure of its financial health and stability which can help investors to decide if Illumina is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Illumina stock.

Illumina Net Worth Analysis

Illumina's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Illumina's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Illumina's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Illumina's net worth analysis. One common approach is to calculate Illumina's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Illumina's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Illumina's net worth. This approach calculates the present value of Illumina's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Illumina's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Illumina's net worth. This involves comparing Illumina's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Illumina's net worth relative to its peers.

Enterprise Value

1.57 Billion

To determine if Illumina is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Illumina's net worth research are outlined below:
Illumina generated a negative expected return over the last 90 days
Illumina currently holds 2.54 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Illumina's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 4.37 B. Net Loss for the year was (1.22 B) with profit before overhead, payroll, taxes, and interest of 2.99 B.
Over 100.0% of Illumina shares are owned by institutional investors
Latest headline from finance.yahoo.com: Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden

Illumina Quarterly Good Will

1.11 Billion

Illumina uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Illumina. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Illumina's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Illumina Target Price Consensus

Illumina target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Illumina's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   25  Buy
Most Illumina analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Illumina stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Illumina, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Illumina Target Price Projection

Illumina's current and average target prices are 85.60 and 162.52, respectively. The current price of Illumina is the price at which Illumina is currently trading. On the other hand, Illumina's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Illumina Market Quote on 17th of March 2025

Low Price83.8Odds
High Price86.11Odds

85.6

Target Price

Analyst Consensus On Illumina Target Price

Low Estimate147.89Odds
High Estimate180.39Odds

162.5172

Historical Lowest Forecast  147.89 Target Price  162.52 Highest Forecast  180.39
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Illumina and the information provided on this page.

Know Illumina's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Hhg Plc2024-12-31
2.2 M
Brown Advisory Holdings Inc2024-12-31
1.9 M
Norges Bank2024-12-31
1.7 M
Corvex Management Lp2024-12-31
1.7 M
Alliancebernstein L.p.2024-12-31
1.7 M
Northern Trust Corp2024-12-31
1.7 M
Bank Of America Corp2024-12-31
1.6 M
Pointstate Capital Lp2024-12-31
1.6 M
Morgan Stanley - Brokerage Accounts2024-12-31
1.5 M
Blackrock Inc2024-12-31
19.3 M
Capital World Investors2024-12-31
18 M
Note, although Illumina's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Illumina's market capitalization trends

The company currently falls under 'Large-Cap' category with a current market capitalization of 13.56 B.

Market Cap

1.61 Billion

Project Illumina's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.23)(0.22)
Return On Capital Employed(0.13)(0.11)
Return On Assets(0.10)(0.10)
Return On Equity(0.18)(0.17)
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1.
When accessing Illumina's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Illumina's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Illumina's profitability and make more informed investment decisions.

Evaluate Illumina's management efficiency

Illumina has return on total asset (ROA) of 0.0264 % which means that it generated a profit of $0.0264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3013) %, meaning that it created substantial loss on money invested by shareholders. Illumina's management efficiency ratios could be used to measure how well Illumina manages its routine affairs as well as how well it operates its assets and liabilities. As of the 17th of March 2025, Return On Tangible Assets is likely to grow to -0.22. In addition to that, Return On Capital Employed is likely to grow to -0.11. At this time, Illumina's Non Currrent Assets Other are very stable compared to the past year. As of the 17th of March 2025, Other Current Assets is likely to grow to about 256.2 M, while Total Assets are likely to drop about 4.1 B.
Last ReportedProjected for Next Year
Book Value Per Share 32.72  34.36 
Tangible Book Value Per Share 1.18  1.12 
Enterprise Value Over EBITDA(33.45)(31.77)
Price Book Value Ratio 3.35  5.39 
Enterprise Value Multiple(33.45)(31.77)
Price Fair Value 3.35  5.39 
Enterprise Value1.5 B1.6 B
Illumina has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue
3.422
Revenue
4.4 B
Quarterly Revenue Growth
(0.02)
Revenue Per Share
27.497
Return On Equity
(0.30)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Illumina insiders, such as employees or executives, is commonly permitted as long as it does not rely on Illumina's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Illumina insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Illumina Corporate Filings

8K
10th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
7th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
12th of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
13A
6th of December 2024
An amended filing to the original Schedule 13G
ViewVerify
Illumina time-series forecasting models is one of many Illumina's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Illumina's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Illumina Earnings Estimation Breakdown

The calculation of Illumina's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Illumina is estimated to be 0.9404 with the future projection ranging from a low of 0.81 to a high of 0.974. Please be aware that this consensus of annual earnings estimates for Illumina is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.86
0.81
Lowest
Expected EPS
0.9404
0.97
Highest

Illumina Earnings Projection Consensus

Suppose the current estimates of Illumina's value are higher than the current market price of the Illumina stock. In this case, investors may conclude that Illumina is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Illumina's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
2545.85%
0.86
0.9404
-7.69

Illumina Earnings History

Earnings estimate consensus by Illumina analysts from Wall Street is used by the market to judge Illumina's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Illumina's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Illumina Quarterly Gross Profit

728 Million

At this time, Illumina's Retained Earnings Total Equity is very stable compared to the past year. As of the 17th of March 2025, Price Earnings To Growth Ratio is likely to grow to 0.30, though Retained Earnings are likely to grow to (1.2 B). As of the 17th of March 2025, Common Stock Shares Outstanding is likely to drop to about 129.7 M. In addition to that, Net Loss is likely to grow to about (3.8 B).
Hype
Prediction
LowEstimatedHigh
84.5187.2589.99
Details
Intrinsic
Valuation
LowRealHigh
77.04101.41104.15
Details
Naive
Forecast
LowNextHigh
81.8684.6187.35
Details
25 Analysts
Consensus
LowTargetHigh
147.89162.52180.39
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Illumina assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Illumina. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Illumina's stock price in the short term.

Illumina Earnings per Share Projection vs Actual

Actual Earning per Share of Illumina refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Illumina predict the company's earnings will be in the future. The higher the earnings per share of Illumina, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Illumina Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Illumina, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Illumina should always be considered in relation to other companies to make a more educated investment decision.

Illumina Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Illumina's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-06
2024-12-310.92280.86-0.0628
2024-11-07
2024-09-300.881.140.2629 
2024-08-06
2024-06-300.90.36-0.5460 
2024-05-02
2024-03-310.040.090.05125 
2024-02-08
2023-12-310.020.140.12600 
2023-11-09
2023-09-300.120.330.21175 
2023-08-09
2023-06-300.020.320.31500 
2023-04-25
2023-03-310.030.080.05166 
2023-02-07
2022-12-310.10.140.0440 
2022-11-03
2022-09-300.30.340.0413 
2022-08-11
2022-06-300.650.57-0.0812 
2022-05-05
2022-03-310.91.070.1718 
2022-02-10
2021-12-310.490.750.2653 
2021-11-04
2021-09-301.141.450.3127 
2021-08-05
2021-06-301.361.870.5137 
2021-04-27
2021-03-311.381.890.5136 
2021-02-11
2020-12-311.111.220.11
2020-10-29
2020-09-300.771.020.2532 
2020-08-06
2020-06-300.670.62-0.05
2020-04-30
2020-03-311.251.640.3931 
2020-01-29
2019-12-311.581.70.12
2019-10-24
2019-09-301.41.930.5337 
2019-07-29
2019-06-301.341.350.01
2019-04-25
2019-03-311.341.60.2619 
2019-01-29
2018-12-311.361.32-0.04
2018-10-23
2018-09-301.261.520.2620 
2018-07-30
2018-06-301.111.430.3228 
2018-04-24
2018-03-311.021.450.4342 
2018-01-30
2017-12-311.221.440.2218 
2017-10-24
2017-09-300.991.110.1212 
2017-08-01
2017-06-300.690.820.1318 
2017-04-25
2017-03-310.640.640.0
2017-01-31
2016-12-310.820.850.03
2016-11-01
2016-09-300.870.970.111 
2016-07-26
2016-06-300.730.860.1317 
2016-05-03
2016-03-310.740.71-0.03
2016-02-02
2015-12-310.820.81-0.01
2015-10-20
2015-09-300.790.80.01
2015-07-21
2015-06-300.770.80.03
2015-04-21
2015-03-310.720.910.1926 
2015-01-27
2014-12-310.780.870.0911 
2014-10-20
2014-09-300.560.770.2137 
2014-07-23
2014-06-300.50.570.0714 
2014-04-22
2014-03-310.440.530.0920 
2014-01-28
2013-12-310.440.450.01
2013-10-21
2013-09-300.40.450.0512 
2013-07-23
2013-06-300.390.430.0410 
2013-04-22
2013-03-310.380.460.0821 
2013-01-28
2012-12-310.410.420.01
2012-10-23
2012-09-300.390.410.02
2012-07-24
2012-06-300.370.40.03
2012-04-23
2012-03-310.330.360.03
2012-02-07
2011-12-310.310.350.0412 
2011-10-25
2011-09-300.230.22-0.01
2011-07-26
2011-06-300.370.380.01
2011-04-26
2011-03-310.310.350.0412 
2011-02-08
2010-12-310.290.290.0
2010-10-26
2010-09-300.240.30.0625 
2010-07-27
2010-06-300.230.260.0313 
2010-04-28
2010-03-310.190.210.0210 
2010-02-04
2009-12-310.20.210.01
2009-10-27
2009-09-300.20.17-0.0315 
2009-07-21
2009-06-300.180.220.0422 
2009-04-21
2009-03-310.190.20.01
2009-02-03
2008-12-310.170.250.0847 
2008-10-21
2008-09-300.160.15-0.01
2008-07-22
2008-06-300.140.160.0214 
2008-04-22
2008-03-310.120.130.01
2008-02-04
2007-12-310.120.140.0216 
2007-10-23
2007-09-300.10.130.0330 
2007-07-24
2007-06-300.060.090.0350 
2007-04-24
2007-03-310.040.060.0250 
2007-02-01
2006-12-310.150.170.0213 
2006-10-17
2006-09-300.080.160.08100 
2006-07-18
2006-06-300.010.070.06600 
2006-04-18
2006-03-310.01-0.0013-0.0113113 
2005-10-24
2005-09-30-0.02-0.010.0150 
2005-07-26
2005-06-30-0.03-0.04-0.0133 
2005-04-27
2005-03-31-0.03-0.010.0266 
2005-02-22
2004-12-31-0.020.04140.0614307 
2004-10-19
2004-09-30-0.04-0.020.0250 
2004-07-14
2004-06-30-0.06-0.050.0116 
2004-04-20
2004-03-31-0.08-0.060.0225 
2004-01-27
2003-12-31-0.09-0.060.0333 
2003-10-16
2003-09-30-0.11-0.080.0327 
2003-07-17
2003-06-30-0.13-0.130.0
2003-04-23
2003-03-31-0.12-0.14-0.0216 
2003-01-28
2002-12-31-0.13-0.120.01
2002-10-23
2002-09-30-0.14-0.120.0214 
2002-07-18
2002-06-30-0.15-0.140.01
2002-04-18
2002-03-31-0.14-0.140.0
2002-01-31
2001-12-31-0.12-0.13-0.01
2001-11-08
2001-09-30-0.1-0.090.0110 
2001-08-07
2001-06-30-0.1-0.10.0
2001-04-25
2001-03-31-0.09-0.080.0111 
2001-01-30
2000-12-31-0.08-0.080.0
2000-10-12
2000-09-30-0.1-0.090.0110 

Illumina Corporate Management

Steven HoffmanSegment SequencingProfile
Pat LeckmanInterim OfficerProfile
Ankur DhingraChief OfficerProfile
Nicole BerryHead RegionAmericasProfile
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
(7.69)
Revenue Per Share
27.497
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0264
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.